Ameriderm Research, the Clinical Research Division of Advanced Dermatology & Cosmetic Surgery (ADCS), is creating a new model for an academically oriented researching clinical medicine practice. This model creates a clinical teaching and clinical researching division not limited to the walls of an institution. ADCS is the largest dermatology group practice in the US, with 62 offices in Florida. Over 450,000 patients are seen per year. These patients represent nearly every age group and every demographic. Patients vary from those who are completely healthy coming for aesthetic services to those having skin cancers and acute to chronic rashes.
Ameriderm Research was established to make available to this vast patient population base access to new drugs and treatments through IRB approved Clinical Trials. These trials are part of those being run throughout the country under FDA supervision. In addition, Ameriderm Research works directly with the pharmaceutical and device industry to devise IRB approved clinical trials that can help develop new drugs and devices. Currently we have over 20 studies going at 3 clinical trial sites (Ormond Beach, Kissimmee, and Jacksonville). But this is just the beginning. The plan is to have multiple regional sites which can draw on recruitment not only from the site itself but from nearby ADCS offices.
In addition, through Leavitt Management Group, Ameriderm Research is an approved NIH contractual facility. As such it works directly with various Universities including University of Central Florida, University of IL, and Wake Forest Medical College. Through these cooperative studies, Ameriderm Research hopes to help elucidate disease processes, the mechanics and pharmacology of treatment response, the pathology of disorders, as well as new high tech data management and device development. Ameriderm Research works with various cosmetic companies to draft and run protocols to test new product development as well as to compare products with competitors. Finally, Ameriderm Research cooperates with several universities to provide their students and medical residents with the opportunities to learn dermatology in depth as well as to contribute opportunities to participate in Clinical Research.